维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="GAULT VA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	N-acetyl-GLP-1:a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression显示文摘	Liu HK Green BD Gault VA	2004	Cell Biol Int2004，28，1：	1
2	Development and ther-apeutic potential of incretin hormone analogues for type 2diabetes 显示文摘	Green BD Irwin N Gault VA	2005	The British Journal of Diabetes and VascularDisease2005，5，3：	1
3	Structurally modi-fied analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as fu-ture antidiabetic agents显示文摘	Gault VA O'harte FP	2004	Curr Pharm Des2004，10，29：	1
4	N-terminal His(7)-modification of glucagon-like peptide-1 (7-36) amide generates dipeptidyl peptidase Ⅳ-stable analogues with potent antihyperglycaemie activity显示文摘	Mooney MH Gault VA	2004	Journal of En-docrinology2004，180，3：	1
5	Sol- uble beta-amyloid reversibly impairs hip- pocampal synaptic plasticity and spatial learning 显示文摘	Holscher C Gengler S Gault VA	2007	Eur J Pharmacol2007，561，：	1
6	Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents显示文摘	Green BD Gault VA O'harte FP	2004	Curr Pharm Des2004，10，29：	1
7	Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease显示文摘	McClean PL Gault VA Harriott P	2010	Eur J Pharmacol2010，630，13：	1
8	Development and therapeutic potential of incretin hormone analogues for type 2 diabetes显示文摘	Gren BD Irwin N Gault VA		0，，03：	1
9	Glucagon- likepeptide-1 analogues enhance synaptic plasticity in the brain:a link between diabetes and Alzheimer's disease显示文摘	McClean PL Gault VA Harriott P	2010	Eur JPharmacol2010，630，13：	1
10	Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide- 1 (7-36) amide have preserved biological activities in vitro conferring improved glucose- lowering action in vivo 显示文摘	Green BD Gault VA Mooney MH	2003	J Mol Endocrinol2003，31，3：	1
11	Novel dipeptidyl peptidase Ⅳ resistant analogues of glucagon-like peptide-1 (7- 36) amide have preserved biological activities in vitro conferring improved glueose-lowering action in vivo显示文摘	Green BD Gault VA Mooney MH	2003	Journal of Molecular Endocrinology2003，31，3：	1
12	Glucose-dependent in- sulinotrepie polypeptide (GIP): anti-diabetic and anti-obesity po- tential显示文摘	GAULT VA FP O'HARTE PR FLATI'	2003	Neuropeptides2003，37，5：	1
13	Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity - related diabetes 显示文摘	Gault VA Irwin N Green BD	2005	Diabetes2005，54，8：	1
14	Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high - fat and cafeteria diets 显示文摘	Gault VA McClean PL Cassidy RS	2007	Diabetologia2007，50，8：	1
15	N-terminal His7-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity显示文摘	Green BD Mooney MH Gault VA	2004	J Endocrinol2004，180，3：	1
16	Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet显示文摘	Gault VA Porter WD Flatt PR	2010	Int J Obes (Lond)2010，34，8：	1
17	Chemical ablation of gastric inhibitory polypeptide receptor action by daily (pro) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of Islet struc- ture in obesity-related diabetes 显示文摘	Gault VA Irwin N Green BD	2005	Diabetes2005，54，8：	1
18	Chemical ablation of gastric inhibitory polypeptide receptor action by daily ( Pro3 )GIP admin- istration improves glueose tolerance and ameliorates insulin resis- tance and abnormalities of islet structure in obesityrelated diabetes 显示文摘	Gault VA Irwin N Green BD	2005	Diabetes2005，54，8：	1
19	Soluble beta-amy- 1oid25-35 reversibly impairs hippocampal synaptic plasticity and spatial learning 显示文摘	Holscher C Gengler S Gault VA	2007	Pharmacol2007，561，13：	1
20	Chemical gastric inhibi-tory polypeptide receptor antagonism protects against obesity,insu-lin resistance,glucose intolerance and associated disturbances inmice fed high-fat and cafeteria diets 显示文摘	Gault VA McClean PL Cassidy RS ef al	2007	Diabetologia2007，50，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示